|
Monday
December 31, 2001
• Vertex,
Proteologics and ZYCOS Subscribe to GeneExpress® Reports,
a Gene Logics Product
Friday
December 28, 2001
• 2001: The Year In Biotech- Plunging Into Proteomics
-Forbes.com
•
The
Genome Revolution: Implications for Biological IP and Licensing To Be
the focus of LES Foundation Address by Leroy Hood
Thursday
December 27, 2001
• Hybrigenics Selects Prolinx's RapXtract 384 Dye Terminator
Removal Kit
Wednesday
December 26, 2001
• Syrrx Closes $18.5 Million Preferred Stock Financing
•
Altus, a Protein Technology Company, Completes a $50 Million Second
Round
•
Bio-Rad
Files Preliminary Proxy Statement to Increase Number Of Authorized Shares
• Compugen to be Listed on the Tel Aviv Stock Exchange
Friday
December 21, 2001
• Call for Speakers for the Proteome Society Seminar:
New Technologies, Novel Approaches to Proteomic Analysis on March 5, 2002,
The Whitehead Institute, Cambridge, MA
Thursday
December 20, 2001
•
GeneProt
on Track with Delivery of Potential Therapeutic Protein Candidates to
Novartis
•
Myriad
Submits Clinical Trial on Prostate Cancer Drug, Flurizan, to the FDA
• Serono Subscribes to Celera's Genomic Databases
Wednesday
December 19, 2001
• Caliper Adopts Stockholders Rights Plan
•
Zeus
Scientific Receives FDA Clearance to Market Multiplexed Autoimmune
Reagent Kit Based on Luminex Technology
• Applied
Molecular Evolution Enters into Collaboration with Lilly to Optimize
Protein Therapeutics
• Protein
Kinases as Therapeutic Targets Conference to Be Held in San Diego, CA,
March 4-5, 2002
• Amgen, Immunex Deal May Be Boon for Their Proteomics,
Bioinformatics Programs -GenomeWeb
Tuesday
December 18, 2001
• Human Proteome Project Settles Down to Business
•
Genomic Solutions Finalize Acquisition of Cartesian Technologies
•
Millipore
and Proteome Systems Launch In-Gel Digest Kits for Protein Sample
Preparation
• IBM and GeneFormatics Partner to Accelerate Drug
Discovery Using Proteomics
• Genicon
Sciences and BD Biosciences Clontech Join Forces to Deliver
the Next Generation of Microarray Tools to Life Science Researchers
Monday
December 17, 2001
•
Integrative
Proteomics Appoints New VP of Antibacterial Division
•
Astex
raises an additional £5.7m ($8.1m)
•
Proteomics
Conference & Exposition to Take Place In Princeton, NJ, March 13-14, 2002
•
New
Function of MDA-7 Protein in Cancer Discovered By Introgen and
Collaborators
•
Caliper
and Bacterial BarCodes to Co-Distribute LabChip® Systems for Clinical
Microbiology
• Boehringer Ingelheim and Structural Bioinformatics
Agree On Research Collaboration Involving New Anti-HIV Compound/Leads
• Xantos Biomedicine Raises Euro 21 Million in Second Round
of Financing
Friday
December 14, 2001
• OGS Announces Extension of Proteomics Agreement with Pfizer
•
Bruker
raises $58.5 mln in IPO, below expectations
• Robertson
Stephens Upgrades Celera to a "Buy"
• SRI
International Applies Advanced Software System to Analyze Metabolic
Pathways of Newly Sequenced Genome
Thursday
December 13, 2001
• MDS - Online Earnings Conference Call
•
Q3DM
and the Genomics Institute of the Novartis Research Foundation
Enter Into Collaborative Agreement to Develop Assays for High Throughput
Cell-Based Screening
• Nanotype
and Xerion Pharma Collaborate on New Generation Protein Biochip
(pdf file)
Wednesday
December 12, 2001
•
GPC
Biotech Receives Orphan Drug Designation in the US for Clinical Phase
II Oncology Compound
•
Celera and Syrrx Announce Structural Proteomics Collaboration;
Celera
says Merck renews osteoporosis pact
• Bruker Daltonics Clarifies Form 4 Filings
• North Carolina Genomics and Bioinformatics Consortium Delivering
on Its Promise
•
New
Chemogenomics Alliance Between MDS Pharma and Iconix
• Entelos Announces Asthma Collaboration With Pfizer
Tuesday
December 11, 2001
• MDS Proteomics Names New CFO and Cites Possible 2002 IPO
•
atugen AG Announces Target Validation Collaboration with OGS
• AxCell to Screen New Protein-Based Drug Target for Pluvita
• De Novo Pharmaceuticals to Assume CeNeS Head Office Lease
• WITA Proteomics Awarded ISO 9001 Certification
Monday
December 10, 2001
• Cognia Announces SBIR Award for Protein Localization Database
System
•
Caliper
and Wako Pure Chemical Industries Form Broad Distribution Agreement
For LabChip® HTS Systems in Japan
• 20/20 GeneSystems, Kodak Strike Protein-Analysis
Partnership -GenomeWeb
Friday
December 7, 2001
•
Vertex and ImClone Subscribe to TRANSPATH Professional From
Cognia
•
Ortho-Clinical
Diagnostics and Caprion Enter into Agreement to Develop Test
for Mad Cow Disease in Humans
• LSBC Will Preview New Research Product and Announce Scientific
News in Three Areas at Annual American Society of Hematology Conference
Thursday
December 6, 2001
• OGS Announces Achievement of Major Protein Patenting Milestone
•
Progenics
and Cytogen Report New Discoveries on Molecular Structure of Key
Prostate Cancer Marker
Wednesday
December 5, 2001
•
Molecular Mining Corporation Announced a Protein Biochip Collaboration
with NextGen Sciences
•
Entelos
to Integrate Platform LSF and LSF ActiveCluster With PhysioLab
To Accelerate In Silico Drug Discovery and Development
• CuraGen Elects New Member to Board of Directors
•
Myriad
CEO Sees Break-Even in Five Years; audio:
Myriad and LabCorp alliance should boost sales
Tuesday
December 4, 2001
•
Eukarion Partners With Proteome Systems and The Buck Institute
To Study Proteomics of Mice With Increased Life Span
•
Ciphergen Announces ProteinChip(R) Biomarker System
• SYN X Pharma Updates Status of Clinical Trials for Global
Registration
•
DGI
Biotechnologies Receives Milestone Payment From Novo Nordisk
for Insulin-Mimic Discoveries - Identifies New Anticancer Target Gene
via Novel Proteomic Mining Technology
• Consensus Pharmaceuticals Names New CEO
• Myriad and LabCorp Form Exclusive Predictive Medicine
Marketing Alliance
• LSBC
Exercises Option to Expand Licensing Agreement in Plant Functional Genomics
with Plant Bioscience Ltd.
• Celera
and Paradigm Genetics Enter Strategic Alliance to Offer Genomic
Technologies to the Plant-based Agricultural Industry
Monday
December 3, 2001
•
GeneProt and Waters Announce Tech Partnership
•
DGI
Launches Proteome Panning, a New Proteomic Mining Technology - Identifies
New Anticancer Target
• IDG
Names New President and CEO of New Business Unit, Bio-IT World, Inc.
Friday
November 30, 2001
•
National
Center for Toxicogenomics Hosts Symposium on Gene Expression And Proteomics
in Environmental Health Research
• Discovery
Partners stock rises on takeover talk
• Incyte
says sues Invitrogen for patent infringment
• GeneData
Introduces Version 3.1 of GeneData Expressionist™ For Microarray
Data Analysis
Thursday
November 29, 2001
• TIGR Develops Major Center for Functional Genomics with
$25 Million From NIAID
•
Emerging Technologies to Increase Drug Candidate Survivability Conference
To Feature New In Silico Techniques March 4-5, 2002 in Philadelphia
•
Cytogen
Receives Approval to Sell New Jersey Tax Credits
•
New
Opportunities and Applications Drive by Breakthroughs in Science and Technology
to be Presented at IBC's 7th Annual Enzyme Technologies March 4-6, 2002,
San Francisco, CA
• WITA to Provide Proteomics Service to Food Giant Nestle
-GenomeWeb
•
Cohesive
Technologies Wins Patent Infringement Lawsuit Against Waters Corporation
Wednesday
November 28, 2001
• Pluvita Subscribes to ProChart Proteomics Database Under
New Access Agreement With AxCell and InforMax
•
IBM and LION Alliance Paves the Way for Faster Drug Discovery
• geneticXchange
and Sandpiper Data Systems Team Up to Solve The Petabyte Problem
for Biotechs
• Silico Insights Attracts Industry and Academic Luminaries
to Scientific Board
•
DPI
Establishes European Headquarters in Basel, Switzerland
• MorphoSys Unveils New Antibody Library
Tuesday
November 27, 2001
•
Dr.
Leroy Hood and Alfred Berkeley to Keynote 2002 Invest Northwest™,
a Life Sciences & CEO Investor Forum
•
Beyond Genomics Names New CTO
•
Myriad
and Biosearch Italia Form Drug Discovery Collaboration; Myriad
to Screen Biosearch's Library of Natural Products
• Cytogen Will Sponsor Conference Call
•
Discovery
Partners International Announces a Significant Expansion Of Its Agreement
with Takeda Chemical Industries
Monday
November 26, 2001
• Applied BioSystems and Millipore Fund Proteomics
Project at U of Tokyo
• GPC
Biotech Signs Agreement with ICOS to Manufacture Antibodies
for Clinical Studies
• Millennium sets Xoma trial deal, licenses protein
• CuraGen to Post its Robertson Stephens Medical Conference
Presentation
•
Incyte
Names New CEO And President and CSO
Wednesday
November 21, 2001
• Syrrx Appoints VP of Intellectual Property and Legal Affairs
•
Eyeing
Proteomics Space, IBM Agrees to Help Proteome Systems Launch
its Proteomics Platform -GenomeWeb
•
IBM
Wins Contract From Proteome Systems -Bloomberg.com
Tuesday
November 20, 2001
• IBM
and Proteome Systems In Protein Research and Drug Discovery Alliance
• John
Wiley and Sons, Inc., and Celera Announce Linking Agreement
•
Dr.
Reddy's Laboratories Limited Announce Agreement for Utilizing Incyte
LifeSeq® Gold Online
•
OGS
Enters Exclusive Alliance with Teva for the Marketing and Distribution
of Vevesca (OGT 918) in Israel
Monday
November 19, 2001
•
MDS
Proteomics Opens World's Premiere Fully Operational Large Scale Proteomics
Research Facility
•
Applied Biosystems and Northeastern University Form Collaboration
to Research Advances in Separation Technology for Proteomics
• MolecularWare
Continues International Market Rollout of DigitalGENOME Software
Friday
November 16, 2001
•
Orphan G-Protein Coupled Receptors (GPCRs) Drug Discovery & Development
Conference To Be Held in Philadelphia, PA, March 18-19, 2002.
• Celera
Acquisition of Axys Pharmaceuticals Approved
Thursday
November 15, 2001
•
AxCell
Biosciences Enters Into Research Collaboration with Mount Sinai School
Of Medicine to Study Proteins Related to the Development of Muscular Dystrophy
And Neurodegenerative Diseases
•
Nine Important New Patents Issued to LSBC
•
Lynx
and the University of California, Davis to Generate Genome-Wide Plant
Gene Expression Data
• Cell Robotics Reports Third Quarter Results; Workstation
Sales Growth Related To Stem Cell, Animal Cloning and Functional Genomics
Research
• Structural
Bioinformatics Recruits New President and COO
• Applera Corporation Declares Dividend
Wednesday
November 14, 2001
•
Myriad
Launches Predictive Medicine Business in Brazil
•
Protea
Biosciences, a New Morgantown-Based Biotechnology Company, Announces
Technology Agreement With WVURC
• Celera
is Highest Ranking Biotech Firm on Deloitte & Touche Technology Fast 500
• Compugen
Names Co-Founder Chairman of U.S. Subsidiary
• Protein Polymer Technologies Reports Third Quarter 2001
Financial Results
Tuesday
November 13, 2001
• New Member of Board of Directors of Integrative Proteomics
• PerkinElmer
Completes Acquisition of Packard BioScience
•
SemBioSys
Genetics Receives $5.5 Million for Study of Protein Production Technology
• Canadian Proteomics Firm Geneka to Open Base in France
-GenomeWeb
Monday
November 12, 2001
• GPC Biotech Reports Q3 2001 Results
• Top
Executives From Eli Lilly and Compaq to Keynote At BioITWorld
• PerkinElmer
Acquisition of Packard BioScience to Close November 13, 2001
Friday
November 9, 2001
• ProteEx Announces Five New Research Projects and Collaborations
•
Myriad
Files Shelf Registration
• IBM, LLNL to Develop New Blue Gene Supercomputer;
Commercialization to Follow -GenomeWeb
Thursday
November 8, 2001
• GPC Biotech to Establish U.S. Genomics Research Center for
Byk Gulden
•
Bio-Rad
Sales Continue Upward Swing
•
Genomic
Solutions Validates Genetac™ Biochip System for Production and
Analysis of Protein Chips
•
Discovery
Partners Announces Appointment of New CFO
•
New
Developments in Protein Kinases & Phosphotases the Focus of Conference
To Be Held in San Diego, CA, March 4-5, 2002
Wednesday
November 7, 2001
• Celera and Compaq Canada Form Exclusive Marketing
Distribution Agreement
•
GeneProt and Bruker Daltonics Plan Large-Scale Deployment of
MALDI-TOF/TOF Mass Spectrometers for High-Throughput Proteomics
• Amplistar
Files An Unprecedented 7 Patent Applications on Colon, Lung and Prostate
Cancer Targets
• Cytogen Reports Q3 2001 Results
• Myriad Reports Results for Q1 of Fiscal 2002
•
Arena
Pharmaceuticals Completes an Initial Human Tissue Mapping of G Protein-Coupled
Receptors
•
MediChem
Reports Q3 2001 Financial Results: Announces Further Cost Savings
• GeneFormatics Appoints Edward Lanphier to Board of Directors
• Informax
Announces the Release of Genomax Version 3.2
• Inpharmatica, Celera in Deal to Deliver New Protein
Structure Database -GenomeWeb
Tuesday
November 6, 2001
•
Syrrx Acquires Certain Assets From Onyx Small Molecules Discovery
Program
•
Kalorama Identifies the 50 Leading Players in $1.5 Billion Proteomics
Industry
• LSBC
Names New President
• LION Announces Partnership with ACE BioSciences
•
MDS
Appoints New Board Member
• Triad Therapeutics Highlights Its NMR-Guided Drug Design
Capabilities At Drug Discovery by Design Conference
• Glycominds Completes $7.1 Million Private Placement
• GNS Launches BIOMINE™ Software for DNA Microarray Analysis
•
Thermo
Finnigan, Paradigm Ink Metabolomics Partnership -GenomeWeb
Monday
November 5, 2001
• Genes Were Easy -- Proteins, Though Perilous, Will Perform!
•
Bruker to Supply Sequenom with Mass Spec for MassArray System
-GenomeWeb
•
Imaging
Research Inc. Announces Release of Version 6.0 Rev. 2.0 Of ArrayVision™
Image Analysis Software
•
GPC
Biotech In-Licenses First Clinical Oncology Compound From Arizona
State University
• Syrrx Appoints New VP of Drug Discovery
• Applied Biosystems Acquires Boston Probes
Friday
November 2, 2001
• Structural Bioinformatics Announces New Version of StructureBank
for Managing 3-D Protein Structures: Relational Database Suite Now Supports
IBM DB2 Universal Database
• NeoPharm Announces Data On Role of SCC-S2 Protein in Tumor
Cell Growth
Thursday
November 1, 2001
•
AxCell
Biosciences Receives First U.S. Patent for Cloning Of Ligand Targets
Technology (See
Patent 6,309,820: Polypeptides Having a Functional Domain of Interest
and Methods of Identifying and Using Same)
•
Genomic
Solutions Reports Q3 Results
•
Cytogen
to Announce Q3 Financial Results and Host Conference Call
•
Protein
Kinases & Phosphotases in Drug Discovery & Development Conference to Be
Held in San Diego, CA, March 4-5, 2002
Wednesday
October 31, 2001
• Biacore and Bruker Daltonics Announce Strategic Collaboration
in Functional Proteomics
•
Beyond
Genomics Licenses Next Generation Technology From Indiana University
•
Genetix,
Sense Proteomic to Collaborate on Protein Arrays -GenomeWeb
•
Frost
& Sullivan to Host Analyst Briefing on US Bioinformatics Market
•
De
Novo Pharmaceuticals and ChemOvation Announce Drug Research
Collaboration
•
New
D&MD Executive Briefing -- In Silico Technology: The Drivers and
Challenges of this Promising Field
• AnVil Informatics Appoints New President and CEO
• Bioinformatics Break Through Limits of Traditional Drug
Discovery Methods
• Myriad
Announces Q1 Results Conference Call
Tuesday
October 30, 2001
• Myriad and Pharmacia Form New Research Collaboration
•
Bruker Daltonics to Webcast Q3 Conference Call on November 5, 2001
• Molecular
Staging Announces Abstract on the Value of Rolling Circle Amplification
in Detecting Allergen-Specific IgE on Microarrays Published
• Celera Adds GeneFormatics' Protein Database to Discovery
System -GenomeWeb
•
Discovery
Partners Reports Q3 2001 Financial Results
•
Bio-Rad
to Report Q3 Financial Results on Thursday, November 8, 2001
• IBC to Hold Protein Kinases Conference in San Diego, CA,
March 6-8, 2002
Monday
October 29, 2001
• Proteomics Surge Sustains Two-Dimensional Gel Electrophoresis
Market Expansion
• Prolinx
Announces Release of Protein Microarray Product Line
• First
Symyx Technologies Proprietary Material for Proteomics Introduced
into Commercial Use
• GeneFormatics'
Structural Proteomics Database Available Through the Celera Discovery
System
• Biosite
Inc. to Present at Chips to Hits Conference; IBC USA 8th Annual International
Microtechnology Event
•
ACLARA
Extends and Expands Technology Access Collaboration With The R.W. Johnson
Pharmaceutical Research Institute
•
ACLARA Announces Third Quarter 2001 Financial Results
•
MediChem
Awarded $750,000 SBIR Grant for Anti-Cancer Drug Design Targeting Human
Topoisomerase I
•
Sangamo
Granted U.K. Patent Covering Methods of Engineering Zinc Finger DNA-Binding
Proteins
•
An
Alternative to Two-Hybrid: Hypromatrix's AntibodyArrays facilitate
protein-protein interaction experiments -TheScientist.com
Friday
October 26, 2001
• Xeotron Awarded Best Poster At Annual IBC "Chips
to Hits" Microtechnology Conference
•
Viaken Lassoes Sun to Co-Develop and Co-Distribute New Informatics
Suite -GenomeWeb
Thursday
October 25, 2001
• Myriad Decodes Pufferfish Genome With International Consortium;
Unique Vertebrate Genome to Aid Discovery of Drug Targets From Human Genome
•
Caliper Announces Q3 2001 Financial Results
• Xerion and Altana Announce Target Validation Collaboration
•
Altus
Turning Proteins into Products™
•
Support
Grows for BSML Standard for Biological Information: NetGenics Joins
IBM and Other Supporters of the XML-Based Specification
• Incyte
posts wider loss
• Cytogen files to offer 10 mln common shares
• DoubleTwist Announces New Online Service for Genomic Research
• Compugen
Reports Q3 Financial Results
• SGI Announces High-Throughput Computing Environment for
Bioinformatics
Wednesday
October 24, 2001
• LSBC Reports 2001 Q3 Financial Results
•
Applied Biosystems profit falls; Celera's loss narrows
• AmberGen
Promises to Speed Up Drug Discovery
• MediChem
Enters into Structural Proteomics Agreement With Cephalon
•
AnVil
Informatics Appoints New Scientific Advisory Committee Member
•
Genomic
Solutions Sells ProGest Unit to University of Calgary -GenomeWeb
Tuesday
October 23, 2001
• Incyte, Genentech in licensing deal for 4 proteins
•
Incyte Reschedules Q3 Fiscal 2001 Results Release And Conference Call
•
CuraGen
to Present Late-Stage Preclinical Results at The American College of Gastroenterology
Meeting
•
TKT
Awarded U.S. Patent Relating to Protein Production and Delivery For Gene
Therapy (See
Patent 6,303,379: Vivo protein production and delivery system for gene
therapy)
Monday
October 22, 2001
• Discovery Partners International Announces Major Chemistry
Collaboration With Merck
•
DoubleTwist Licenses Prophecy Database and Tools Suite, Prophecy ToolKit
and Genomatix Promoter Resource Database to Organon
• Whitehead
Institute's Dr. Eric Lander to Present Opening Keynote Address At
BioITWorld Conference & Expo
• Cytogen Names VP Investor Relations
Friday
October 19, 2001
• Ciphergen Conference Call and Webcast
•
Protein
Kinases & Phosphotases in Drug Discovery & Development Conference To Be
Held in San Diego, CA, March 4-5, 2002
• Eichrom
Technologies Announces the Formation of Eprogen, Offering Innovative
Technologies in Proteomics
• Gryphon
Sciences Grants Nonexclusive Native Chemical Ligation Sublicense to
Invitrogen for Studying Protein Function
• Software Solutions to Proteomics Problems -The-Scientist.com
•
NASA,
NIH Award BSI Proteomics $800,000 in SBIR Grants -GenomeWeb
•
Protecting
the Patentability of 3-D Protein Structures -GenomeWeb
Thursday
October 18, 2001
• Genomic Solutions Awarded Patent for Novel Proteomic Technology
•
Biacore
Interim Report January - September 2001
• Luminex Reports Third Quarter Results Exceeding Consensus
Analyst Estimates
•
Intel
Backs Protein Project -Wired.com
Wednesday
October 17, 2001
• GeneFormatics Closes $22M in Series C Financing Round -GenomeWeb
Tuesday
October 16, 2001
• MediChem to Manage Beamline at Argonne's Advanced Photon
Source
•
Structural
GenomiX Appoints New CSO
• DoubleTwist Licenses Prophecy Database and Tools Suite to
GPC Biotech
• Waters
Corporation Q3 2001 Financial Results Webcast Invitation
•
MDS
Pharma Announces Addition of BIACORE 3000 System
• Silico
Insights Expands Informatics Platform
Monday
October 15, 2001
• SYN X Pharma Announces Development and Manufacturing Agreement
•
Alpha Innotech and Proteome Systems Announce Product Collaboration
• Proteomics Push to the Forefront of Biotechnology Research,
Says Technical Insights
•
Hair,
Hair, the Protein's Here -Wired.com
• Syrrx
Awarded $100,000 SBIR Grant to Develop Next Generation High-Throughput
Crystallization Robot
• Proteomic Research Services, Inc. Begins Operations In Ann
Arbor, Michigan
• Unraveling
Mysteries of the Human Genome At UC Berkeley Extension
Thursday
October 11, 2001
• Lynx Invites You to Participate in Third Quarter 2001 Conference
Call
•
Cell
Robotics' Launches Two New Workstation Products; Workstations Target
Functional Genomics
• Phylos Announces Strategic Collaboration With Lawrence
Livermore National Lab For High Throughput Protein Production
• Aptagen Adds Advisor to Scientific Advisory Board
Wednesday
October 10, 2001
• Proteome Systems to Improve EPO Drug Test
• LSBC
to Release Q3 Earnings and Host Conference Call
• AxCell Biosciences and NCI Prepare to Enter Into A Cooperative
Agreement
• Cytogen's
CEO H. Joseph Reiser talks to The Wall Street Transcript
• ProteEx to Present at the 9th Annual BioPartnering Europe
(BPE) Conference
•
Incyte
and Epoch Biosciences Enter Into License, Development And Supply
Alliance
Tuesday
October 9, 2001
•
Proteome
Systems and Shimadzu Biotech Complete 1st Stage of The Chemical
Printer Development
•
GeneProt Names New VP, Business Development
•
New
D&MD Report -- Proteomics: The Landscape of Innovative Technologies
and Emerging Companies, 2nd Edition
• Structural
GenomiX Names New Chief Business Officer
• Applied
Biosystems and Celera Q1 FY 2002 Financial Results Scheduled
for Release October 24, 2001
•
Myriad
Discovers Novel Anti-Cancer Drug ; Myriad
Says It Finds Cancer Drug Target
•
Applied
Precision's arrayWoRx Is the First Microarray Scanner to Offer Image
Interpretation With Upstream Analysis
Monday
October 8, 2001
• Ciphergen Enters Collaboration With Pfizer for Protein
Biomarker Discovery
•
Frost
& Sullivan to Host Proteomics: The World 2D Gel Electrophoresis Market
Analyst Briefing
•
MediChem'
CEO to Present at UBS Warburg LLC Global Life Sciences Conference ;
MediChem
and Pharmacia Enter into Medicinal Chemistry Collaboration
• Caliper and Agilent Introduce Cell Assays for 2100
Bioanalyzer
•
Entelos
and Zen-Bio Announce Collaboration to Discover Therapeutics for
Obesity
• 3-Dimensional Pharmaceuticals Announces $4 M Payment From
Centocor in Connection with Thrombin Inhibitor Program
Friday
October 5, 2001
• Incyte Sets Announcement Date for Q3 2001 Earnings Release
•
Cytogen
to Participate in UBS Warburg Global Life Sciences Conference
•
Protein
Kinases World Summit to Be Attended by International Research Community
in Newark, NJ, October 15-16, 2001
• MolecularWare, Applied Precision Strike 'Seven-Figure'
Deal -GenomeWeb
Thursday
October 4, 2001
• New Dates Announced for IBC's Protein and Peptide
Drug Delivery Conference November 29-30, 2001 San Francisco, CA.
•
TurboBLAST Now Available On New IBM eServer
•
Myriad
and U of Utah Publish Pioneering HIV Research in CELL
• Chips to Hits® Meeting to Happen October 28, 2001, San
Diego, CA
•
Phylos
Continues to Extend Patent Portfolio for its PROfusion(TM) Technology
Platform
• BioMicro Seeks $10M Series B to Launch Novel Microfluidics
Platform -GenomeWeb
•
GeneFormatics
Expects to Announce Slew of Deals in Near Future -GenomeWeb
•
Protein Blocks Could Inhibit AIDS -Wired.com
Wednesday
October 3, 2001
•
New
GeneProt Corporate Headquarters And First Large-Scale Proteomics
Discovery Center In The U.S.
• Geneformatics
Forms Strategic Partnerships in Structural Proteomics With Three Bruker
Companies
• Genomic Solutions Announces Divestiture of Proteomic Contract
Services Unit
• Phylos Names Senior Director of Business Development
• Ausam Biotech to Ink Licensing Deal for Proteomic-Based
Diagnostic -GenomeWeb
Tuesday
October 2, 2001
• 20/20GeneSystems Launches New Proteomics Product
•
Interomex
BioPharmaceuticals Raises $6.3 Million and Appoints Internationally
Renown Scientific Advisory Board
• Qiagen TAGZyme™ System for protein study and purification
Monday
October 1, 2001
• Structural GenomiX and Celera Sign Marketing and
Distribution Agreement
•
Integrative
Proteomics and the U of Toronto Join Efforts to Map Bacterial Proteomes
• MDS
Proteomics Bolsters Informatics Team with Addition of Leading Data
Analysis Software Development and Mathematical Research Experts
|
